perindopril has been researched along with Renal Insufficiency in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chalmers, J; Coresh, J; Herrington, W; Li, Q; Mancia, G; Marre, M; Mohammedi, K; Perkovic, V; Poulter, N; Rodgers, A; Williams, B; Woodward, M | 1 |
| Buniatian, ND; Lednev, OA; Sergeev, SV; Zaslavskaia, RM | 1 |
| Hiromi, Y; Kato, K; Kawahara, H; Muraoka, I; Nabeshima, T; Seno, H; Takasu, R; Yamada, S | 1 |
| Belair, MF; Chainey, A; Chevalier, J; Mandet, C; Michel, O; Myara, I; Plante, GE; Renaud, IM | 1 |
| Aarons, L; Parker, E; Resplandy, G; Rowland, M | 1 |
| Collier, D; Cruickshank, K; Hughes, AD; Lacy, PS; O'Rourke, M; Stanton, A; Thom, SM; Thurston, H; Williams, B | 1 |
| Bertrand, M; Boersma, E; Brugts, JJ; Chonchol, M; Deckers, JW; Ferrari, R; Fox, K; Remme, WJ; Simoons, ML | 1 |
| Dratwa, M; Lachaud-Pettiti, V; Meyrier, A; Sennesael, J | 1 |
| Busuttil, W; Galea, J; Manché, A | 1 |
| Glasser, SP | 1 |
| Bree, F; Nguyen, P; Resplandy, G; Tillement, JP; Urien, S | 1 |
1 review(s) available for perindopril and Renal Insufficiency
| Article | Year |
|---|---|
Angiotensin converting enzyme inhibitors: are they preferred first-line therapy?
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Comorbidity; Diabetic Nephropathies; Endothelium, Vascular; Humans; Hypertension; Perindopril; Randomized Controlled Trials as Topic; Renal Insufficiency; Treatment Outcome | 2000 |
6 trial(s) available for perindopril and Renal Insufficiency
| Article | Year |
|---|---|
Associations between body mass index and the risk of renal events in patients with type 2 diabetes.
Topics: Aged; Albuminuria; Blood Glucose; Body Mass Index; Creatinine; Diabetes Mellitus, Type 2; Drug Combinations; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Indapamide; Kidney; Kidney Diseases; Male; Middle Aged; Obesity; Overweight; Perindopril; Reference Values; Renal Insufficiency | 2018 |
Elimination kinetics of quinaprilat and perindoprilat in hypertensive patients with renal failure on haemodialysis.
Topics: Administration, Oral; Adult; Angiotensin-Converting Enzyme Inhibitors; Chromatography, High Pressure Liquid; Half-Life; Humans; Hypertension; Indoles; Male; Metabolic Clearance Rate; Middle Aged; Perindopril; Quinapril; Renal Dialysis; Renal Insufficiency; Tetrahydroisoquinolines | 2003 |
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Renal Insufficiency; Sodium Chloride Symporter Inhibitors; Treatment Outcome | 2006 |
The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Disease; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Perindopril; Renal Insufficiency; Severity of Illness Index; Treatment Outcome; Ventricular Function, Left | 2007 |
Fixed low-dose perindopril-indapamide combination in hypertensive patients with chronic renal failure.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Chronic Disease; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Indoles; Male; Middle Aged; Perindopril; Renal Insufficiency | 1998 |
Tolerance to ACE inhibitors after cardiac surgery.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Bypass; Drug Hypersensitivity; Enalapril; Feasibility Studies; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Indoles; Length of Stay; Middle Aged; Myocardial Infarction; Perindopril; Prognosis; Renal Insufficiency | 1999 |
4 other study(ies) available for perindopril and Renal Insufficiency
| Article | Year |
|---|---|
[Use of prestarium (perindopril) in patients with polymorbidity syndrome (AH, DM, nephropathy)].
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Blood Urea Nitrogen; Creatinine; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Perindopril; Renal Insufficiency; Treatment Outcome | 2009 |
Long-term protection of obese Zucker rat kidneys from fibrosis and renal failure with an angiotensin-converting enzyme inhibitor/diuretic combination.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diuretics; Drug Combinations; Fibrosis; Indapamide; Kidney Function Tests; Male; Metabolic Clearance Rate; Obesity; Perindopril; Proteinuria; Rats; Rats, Zucker; Renal Insufficiency | 2004 |
The pharmacokinetics of perindoprilat in normal volunteers and patients: influence of age and disease state.
Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Creatinine; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Indoles; Injections, Intravenous; Male; Middle Aged; Models, Biological; Perindopril; Renal Insufficiency | 2005 |
Specific and high affinity binding of perindoprilat, but not of perindopril to blood ACE.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Proteins; Drug Interactions; Erythrocytes; Humans; Indoles; Kinetics; Liver Failure; Peptidyl-Dipeptidase A; Perindopril; Protein Binding; Renal Insufficiency; Sensitivity and Specificity; Serum Albumin | 1992 |